Higher risk of kidney function decline with entecavir than tenofovir alafenamide in patients with chronic hepatitis B.
Chan-Young JungHyung Woo KimSang Hoon AhnSeung-Up KimBeom Seok KimPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
ETV was associated with a higher risk of kidney function decline than TAF in patients with treatment-naïve CHB. Therefore, further prospective randomized studies are needed.